Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
EXACT Sciences Corporation
EXASCurrent price
65.54 USD
-0.89 USD (-1.34%)
Last closed
67.39 USD
Company
www.exactsciences.com
ISIN
US30063P1057
Sector
Healthcare
Industry
Diagnostics & Research
Exchange
NASDAQ
Capitalization
10 862 628 864 USD
Yield for 12 month
-12.96 %
1Y
3Y
5Y
10Y
15Y
EXAS
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin. Address: 5505 Endeavor Lane, Madison, WI, United States, 53719
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
76.74 USDP/E ratio
–Dividend Yield
–Current Year
+2 499 766 000 USD
Last Year
+2 084 279 000 USD
Current Quarter
+699 264 000 USD
Last Quarter
+637 524 000 USD
Current Year
+1 845 566 000 USD
Last Year
+1 509 885 000 USD
Current Quarter
+486 105 000 USD
Last Quarter
+467 424 000 USD
Key Figures EXAS
1 year
3 years
5 years
10 years
EBITDA
-68 901 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-2.71 %
PEG Ratio
-1.07
Return On Equity TTM
-5.6 %
Wall Street Target Price
76.74 USD
Revenue TTM
2 612 011 008 USD
Book Value
17.29 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
12.4 %
Dividend Yield
–
Gross Profit TTM
1 509 885 000 USD
Earnings per share
-0.95 USD
Diluted Eps TTM
-0.95 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-6.7 %
Dividend Analytics EXAS
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History EXAS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation EXAS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
2000
Enterprise Value Revenue
4.874
Price Sales TTM
4.1587
Enterprise Value EBITDA
183.7729
Price Book MRQ
3.4195
Financials EXAS
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators EXAS
For 52 weeks
40.62 USD
80.56 USD
50 Day MA
52.57 USD
Shares Short Prior Month
13 592 719
200 Day MA
58.81 USD
Short Ratio
4.66
Shares Short
13 815 277
Short Percent
7.55 %
BeatStart